KATHRYN CORNELL: Open Payments
NPI 1588030134 · INDEPENDENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $137 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Lilly USA, LLC | 2 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: UBRELVY, BREZTRI, CAPLYTA, JARDIANCE, QULIPTA, FARXIGA, ZEPBOUND, MOUNJARO.
Industry payments across KS — which companies pay providers there.
